Search

everythinglearnresearchcommunity

for

Search:↓

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Docetaxel is effective against various cancers but mainly causes neutropenia.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Promising cancer treatments were found, but the manufacturer closed.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The drug combination was safe and showed promise in treating advanced tumors.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cetuximab can cause eyelash growth, which is rare but manageable.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Tofacitinib helped a woman regrow hair with no major side effects.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.